Enovis Corp (ENOV)
Enovis Corporation is a healthcare company focused on medical technology for musculoskeletal care in the United States and international markets. Its operations are organized into two segments. Prevention and Recovery includes orthopedic bracing, therapy products, bone growth stimulators, compression and vascular therapy systems, electrical stimulators for pain management, and related rehabilitation products used by healthcare professionals treating musculoskeletal conditions. Reconstructive develops and markets surgical solutions designed to support mobility and patient outcomes, including implants, instrumentation, and enabling technologies for joint replacement, limb reconstruction, and foot and ankle procedures. The company also supplies products used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Enovis distributes its products through independent distributors, direct sales representatives, and patient channels. Formerly known as Colfax Corporation, the company was founded in 1995 and is headquartered in Wilmington, Delaware.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-ENOV
|
$31.83
|
19.4% Upside
|
Undervalued
|
$40.73
|
52.8% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-1.4x
|
1.0x
|
0.7x
|
1.545 B
|
2.913 B
|
47.7%
|
98.3%
|
1.0
|
—
|
-3.2%
|